Flamm Robert K, Weaver Mellany K, Thornsberry Clyde, Jones Mark E, Karlowsky James A, Sahm Daniel F
Focus Technologies, 13665 Dulles Technology Drive, Suite 200, Herndon, VA 20171-4603, USA.
Antimicrob Agents Chemother. 2004 Jul;48(7):2431-6. doi: 10.1128/AAC.48.7.2431-2436.2004.
For the period from 1999 to 2002 in the United States, the in vitro susceptibilities of 52,637 Pseudomonas aeruginosa isolates to 10 antimicrobial agents were evaluated. The isolates were from 29 laboratories, 11 of which participated in The Surveillance Network for four consecutive years. Isolates were collected from adult patients (> or =18 years of age) in intensive care units (ICU), non-ICU inpatients, nursing home patients, and outpatients; data were analyzed to evaluate factors, such as year of isolation, patient age group, isolate specimen source, and patient type (hospitalized patients [ICU, non-ICU, or nursing home] or outpatients). Rates of resistance for the 4-year period were highest for isolates from patients in ICU and 18- to 39-year-old patients and for isolates from the lower respiratory tract. Resistance decreased with age. Resistance was lowest in isolates from outpatients, in isolates from > or =70-year-old patients, and from specimens from the upper respiratory tract. Multidrug resistance (MDR) (resistance to three or more antimicrobial agents) accounted for 24.9% of all isolates. The MDR rate was highest in isolates from patients in nursing homes (29.9%) and ICU (29.5%).
1999年至2002年期间,在美国对52637株铜绿假单胞菌分离株对10种抗菌药物的体外敏感性进行了评估。这些分离株来自29个实验室,其中11个实验室连续四年参与了监测网络。分离株取自重症监护病房(ICU)的成年患者(≥18岁)、非ICU住院患者、疗养院患者和门诊患者;对数据进行分析以评估各种因素,如分离年份、患者年龄组、分离株标本来源和患者类型(住院患者[ICU、非ICU或疗养院]或门诊患者)。四年期间,来自ICU患者、18至39岁患者以及下呼吸道分离株的耐药率最高。耐药率随年龄增长而降低。门诊患者分离株、≥70岁患者分离株以及上呼吸道标本分离株的耐药率最低。多重耐药(MDR)(对三种或更多抗菌药物耐药)占所有分离株的24.9%。疗养院患者(29.9%)和ICU患者(29.5%)分离株的MDR率最高。